Obesity is linked to many common diseases, such as type 2 diabetes, heart disease, fatty liver disease and knee ...

A new definition of obesity could help people with excess weight better understand the health risks they now face and ...

A group of global experts is proposing a new way to define and diagnose obesity by reducing the emphasis on the controversial ...

John Flavin, Portal Innovations CEO, joins 'Fast Money' to talk what we can expect to see from the J.P. Morgan Healthcare conference this year.

Obesity is a complex health issue that affects millions of people worldwide. Unfortunately, it is often accompanied by stigma and discrimination, which can have a significant negative impact on ...

Big money, big ideas and big egos — the art world has all the necessary ingredients ... Rie Kudan revealed that around 5% of the work was generated, word-for-word, by AI.

A Microsoft 365 subscription includes Microsoft Word for writing, PowerPoint for creating presentations, Outlook for email and OneDrive for cloud storage -- and typically, it doesn't come cheap.

In the beginning was the Word, and the Word was with God, and the Word was God. He was in the beginning with God. All things were made through him, and without him was not any thing made that was made ...

Dizziness can occur in relation to type 2 diabetes due to low or high blood sugar, diabetes medications, or dehydration. A doctor can help determine the cause and how to manage or treat it. Type 2 ...

In a first, scientists at the World Health Organisation (WHO) have endorsed a new class of medicines known as GLP-1 receptor agonists, which mimic a hormone that regulates appetite and blood sugar ...

In a study, people who took Zepbound had fewer breathing interruptions. The FDA has expanded the approval of Eli Lilly’s obesity medication Zepbound to include treating moderate to severe ...

Illustration: Elizabeth Smelov Novo Nordisk shares dived Friday after an experimental anti-obesity treatment missed expectations in a study, denting its chances of becoming the company’s next ...